Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AssigneeAstute Medical, Inc.
InventorsJoseph Anderberg, Jeff Gray, Paul Mcpherson, Kevin Nakamura, James Patrick Kampf
Life of this patent
Estimating the term…
Loading patent…
AssigneeAstute Medical, Inc.
InventorsJoseph Anderberg, Jeff Gray, Paul Mcpherson, Kevin Nakamura, James Patrick Kampf
Estimating the term…
The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Heat shock 70 kDa protein 1, Alpha-1-antitrypsin Neutrophil elastase complex, Stromelysin-1:Metalloproteinase inhibitor 2 complex, 72 kDa type IV collagenase:Metalloproteinase inhibitor 2 complex, Insulin-like growth factor 1 receptor, Myeloid differentiation primary response protein MyD88, Neuronal cell adhesion molecule, and Tumor necrosis factor ligand superfamily member 10 as diagnostic and prognostic biomarkers in renal injuries.
A method for evaluating renal status in a subject, comprising:
15-23. (canceled)
(canceled)
(canceled)
32-54. (canceled)
56-127. (canceled)
Dependencies are inferred from the claim text.